Clinical Trials in Texas

Showing 3601-3620 of 15,101 trials

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

NCT05636228

Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK). Participants will return for a follow up visit 1 week after end of treatment.

Acute Infectious Keratoconjunctivitis

Invirsa, Inc.93 participantsStarted Jun 2023

Glendale, California, United States • Pasadena, California, United States • Largo, Florida, United States +9 more locations

Active Not RecruitingPhase 355 miles

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

NCT04987203

This study will be comparing tivozanib in combination with nivolumab to tivozanib alone in subjects with advanced Renal Cell Carcinoma (RCC) who have had 1 or 2 prior lines of therapy, one of which was an Immune Checkpoint Inhibitor (ICI).

Renal Cell Carcinoma

AVEO Pharmaceuticals, Inc.343 participantsStarted Sep 2021

Duarte, California, United States • Irvine, California, United States • La Jolla, California, United States +136 more locations

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Find Trials by Condition in Texas

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

ERG Components in Schizophrenia and Bipolar Disorder Type I

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

PTG-300 in Subjects With Hereditary Hemochromatosis

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

CCT-102 or Expectant Management in Delayed Pregnancy Loss

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

STICH3C Cardiac Magnetic Resonance Observational Study